Freestone Grove Partners LP Elanco Animal Health Inc Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Freestone Grove Partners LP holds 1,684,190 shares of ELAN stock, worth $18.9 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,684,190Holding current value
$18.9 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
438Shares Held
448MCall Options Held
1.16MPut Options Held
1.12M-
Dodge & Cox San Francisco, CA83.2MShares$935 Million0.63% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$575 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$548 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$262 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A620.4MShares$230 Million11.79% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.33B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...